LENZ Therapeutics (LENZ) Times Interest Earned (2020)

LENZ Therapeutics (LENZ) reported Times Interest Earned of -$64.6 for Q2 2020.

LENZ Therapeutics (LENZ) Times Interest Earned (2020) Analysis & Trends

LENZ Therapeutics (LENZ) has 1 years of Times Interest Earned data on file, last reported at -$64.6 in Q2 2020.

  • Times Interest Earned for Q2 2020 came in at -$64.6, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was -$1137.4 (changed N/A YoY), and the FY2020 annual result was -$337.5, changed N/A from the prior year.
  • Times Interest Earned was little changed at -$64.6 in Q2 2020 per LENZ's latest filing.
  • Over five years, Times Interest Earned peaked at -$64.6 in Q2 2020 and troughed at -$64.6 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 3.58
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 11.50
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -258.33
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 547.67
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - 11.79
10 LENZ Therapeutics 192.19 Mn 192.19 Mn 825,000.00 -

Historic Data

Download Data
DateValue
Jun 30, 2020 -64.60